Other studies have used in vitro models of NK cell dysfunction to circumvent this limitation, activating NK cells with cross-linking antibodies against NK cell receptors (45, 46) or with tumor cells, but if such conditions are relevant to in vivo NK cell dysfunction is unknown. The gene discussed is KLRD1; the disease is neoplasm.